Dressings in Massachusetts

Boston BGEcare Inc. is a Massachusetts-based medical consumables and contract manufacturing company specializing in wound care, personal protective equipment (PPE), compression garments, ostomy products, advanced wound care solutions, and operating room/surgical supplies. The company operates as both a direct product supplier and an original equipment manufacturer (OEM) partner, offering turn-key contract manufacturing services from product ideation through commercialization. BGEcare serves healthcare providers and manufacturers requiring transparent, efficient, and resilient supply chain solutions. The company maintains quality and regulatory compliance capabilities as core operational competencies, supporting FDA and other regulatory pathways. Product lines span traditional wound care (gauze, bandages, dressings), compression therapy systems, ostomy accessories, advanced wound management technologies, and surgical/OR consumables. BGEcare positions itself as a manufacturing partner for companies seeking to develop, scale, or outsource production of medical devices and consumables, emphasizing operational transparency and supply chain resilience.

Advanced Medical Solutions Group plc (AMS) is a world-leading independent developer and manufacturer of innovative tissue-healing technologies serving surgical, wound care, and specialty medical markets globally. The company operates 14 manufacturing and R&D locations across Europe, Asia, and other regions, with >1,500 employees and distribution partnerships in >90 countries. Core product lines include: (1) Surgical—adhesives and sealants for internal wound closure, biosurgicals (collagen-based hemostats and regenerative products), and sutures and related supplies; (2) Wound Care—exudate management systems, infection control dressings, and other advanced wound technologies including hydrogels. AMS also operates a dental division and contract manufacturing services. Key subsidiary and acquired brands include RESORBA (biosurgicals and sutures, Nürnberg and Domazlice), Raleigh Adhesive Coatings (woundcare coatings, Stafford), ActivHeal (wound care brand), Peters Surgical (clips and sutures, Domalain France; suture manufacturing in Thailand and India), Catgut GmbH (sutures, Markneukirchen), and Connexicon Medical (tissue adhesives R&D, Dublin). Manufacturing capabilities span bulk foam roll-stock, collagen processing, suture extrusion, and specialized coatings and formulations. The company is listed on the London Stock Exchange (LSE), with FY24 revenue of £177.5M and adjusted profit of £29.4M. Regulatory standing implies FDA, ISO 13485, and CE mark compliance across product portfolio, though specific certifications are not detailed on fetched pages. AMS positions itself as a surgical powerhouse and leader in tissue regeneration and hemostasis.

Beeken Biomedical is a medical device company specializing in hemostatic wound care and bleeding control products. The company develops, licenses, and commercializes advanced surgical dressings and trauma care solutions under the NuStat® brand. The flagship product line is built on proprietary Hemafiber™ technology—a hemostatic fiber matrix that accelerates clot formation through absorption and local concentration of clotting factors at the wound site. NuStat® products are FDA Class II cleared for temporary control of internal organ space bleeding in class III and IV hemorrhage cases, as well as for severely bleeding wounds including surgical and traumatic injuries. The company serves multiple markets: hospital surgical and trauma departments, first responders (military, law enforcement, fire, and EMS), and public/private safety facilities. NuStat® OTC products meet or exceed U.S. Department of Defense specifications for quality and functionality and align with Stop the Bleed® initiatives. Beeken Biomedical holds FDA 510(k) clearance and maintains product compliance with relevant medical device regulations. The company combines B2B hospital/surgical supply channels with direct-to-consumer and public safety distribution.

Ogenix manufactures EPIFLO, an FDA-cleared topical oxygen therapy device designed for 24/7 chronic wound treatment. The 3-ounce portable system delivers continuous oxygen therapy to address diabetic foot ulcers, venous stasis ulcers, pressure injuries, surgical wounds, burns, and other non-healing chronic wounds. EPIFLO functions as an adjunct therapy suitable for outpatient and ambulatory wound care settings, enabling clinicians and patients to integrate advanced oxygen-based wound healing into standard clinical management protocols.

AliMed, LLC is a medical supplies manufacturer and distributor based in Dedham, Massachusetts, with over 50 years of industry experience since 1970. The company specializes in innovative healthcare products including durable medical equipment, rehabilitation aids, operating room accessories, and ergonomic solutions. AliMed's core product portfolio encompasses patient positioning systems (AliBlue™ Gel and AliBlue™ Lite hybrid gel-foam positioners), surgical positioning straps and supports, orthopedic footwear and insoles, wheelchair cushions, hand and wrist braces, lower extremity positioning aids, and therapy equipment. The company serves hospitals, ambulatory surgery centers, post-acute care facilities, and home care settings. AliMed is recognized for customization capabilities, responsive U.S.-based customer service, same-day shipping on in-stock orders, and volume pricing. The company was named Manufacturer of the Year by the Massachusetts Legislative Caucus.

Advamedica Inc. is a deep science medtech company specializing in novel biomaterial-based medical devices. The company leverages proprietary biomaterial technology and manufacturing platforms to develop innovative hemostatic, surgical, and wound care products for pre-hospital, intra-operative, and post-operative clinical settings. Their product portfolio includes FDA-cleared hemostatic patches and surgical hemostats based on chitosan and protonated bioadhesive technology, as well as advanced wound care dressings. Advamedica's solutions are designed to improve patient outcomes through strong bioadhesion, ease of removal, and barrier properties against bacterial penetration, with products available in 40+ countries.

Marine Polymer Technologies, Inc. (MPT) is a medical device company specializing in advanced biomaterials for hemostasis, wound healing, and severe bleeding control. Founded in 1992, the company develops proprietary products engineered from poly-N-acetyl glucosamine fibers derived from microalgae. The company's primary product lines include SyvekExcel® for vascular catheterization hemostasis, Talymed® for chronic and acute wound management (diabetic foot ulcers, venous leg ulcers, pressure wounds), and mrdh® for rapid severe bleeding control, including use in coagulopathic patients. MPT's solutions are designed for high reproducibility and safety across surgical, interventional, and wound care settings. Talymed® has received Medicare Pass-Through Status designation, indicating recognition of clinical significance. The company serves acute care hospitals, interventional radiology centers, wound care clinics, and surgical facilities. Manufacturing capabilities center on proprietary fiber technology and hemostatic/dressing product assembly. Products are indicated for healthcare provider and patient use across multiple procedure types and patient populations.

Jiujiang Huada Medical Dressing Co., Ltd., established in 2003, is a medical consumables manufacturer based in Gongqing city, Jiujiang, Jiangxi Province, China. The company employs 260 personnel and specializes in the design, manufacture, and distribution of medical-grade gauze products and sterilization packaging materials. Core product lines include non-sterile and sterile gauze swabs, 100% cotton gauze rolls (4-ply), gauze bandages, laparotomy sponges (lap sponges) with X-ray detectable chips, and sterilization pouches and reels in various configurations. All gauze products are manufactured from bleached cotton and are designed for wound cleaning, coverage, and secretion absorption in medical institutions and care settings. Sterilization pouches and reel rolls are fabricated from medical-grade paper and multilayer film materials suitable for autoclaving. The company serves global markets and participates in major medical trade exhibitions including CMEF Shanghai and Hospitalar. Manufacturing capabilities include OEM production and customization. No specific regulatory certifications (FDA 510(k), ISO 13485, or CE marking) are mentioned on the website.